D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 75 Citations 16,304 317 World Ranking 12118 National Ranking 395

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Platelet

Ton Lisman mostly deals with Internal medicine, Surgery, Liver transplantation, Hemostasis and Liver disease. His Internal medicine research incorporates elements of Gastroenterology, Endocrinology and Immunology. His Immunology research integrates issues from Antithrombin and Coagulation.

His work on Thrombosis, Coagulopathy and Hepatectomy is typically connected to Central venous pressure as part of general Surgery study, connecting several disciplines of science. The concepts of his Hemostasis study are interwoven with issues in Blood coagulation test, Chronic liver disease, Cirrhosis, Thrombomodulin and Intensive care medicine. While the research belongs to areas of Liver disease, Ton Lisman spends his time largely on the problem of Von Willebrand factor, intersecting his research to questions surrounding Disseminated intravascular coagulation.

His most cited work include:

  • Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences (381 citations)
  • Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. (380 citations)
  • Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. (380 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Gastroenterology, Liver transplantation, Cirrhosis and Surgery. His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Myocardial infarction. His study in Gastroenterology is interdisciplinary in nature, drawing from both Anticoagulant and Sepsis.

As a part of the same scientific study, Ton Lisman usually deals with the Liver transplantation, concentrating on Pathology and frequently concerns with Bile duct. His study looks at the intersection of Cirrhosis and topics like Platelet with Biochemistry and Liver regeneration. His Thrombosis research incorporates themes from Odds ratio and Risk factor.

He most often published in these fields:

  • Internal medicine (55.42%)
  • Gastroenterology (31.23%)
  • Liver transplantation (25.19%)

What were the highlights of his more recent work (between 2019-2021)?

  • Internal medicine (55.42%)
  • Gastroenterology (31.23%)
  • Liver disease (17.63%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Gastroenterology, Liver disease, Cirrhosis and Liver transplantation. His Internal medicine and Coagulation, Thrombosis, Von Willebrand factor, Portal vein thrombosis and Heparin investigations all form part of his Internal medicine research activities. His Coagulation research is multidisciplinary, incorporating perspectives in Platelet and Antithrombin.

The study incorporates disciplines such as Low molecular weight heparin, Fibrinolysis and Thrombin in addition to Gastroenterology. The various areas that Ton Lisman examines in his Liver disease study include Thrombelastography, Fresh frozen plasma, Review article and Hemostasis, Hemostatics. As a member of one scientific family, Ton Lisman mostly works in the field of Cirrhosis, focusing on Thrombomodulin and, on occasion, Healthy volunteers, Whole blood, Coagulation testing, Hematocrit and Platelet-poor plasma.

Between 2019 and 2021, his most popular works were:

  • In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. (27 citations)
  • Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute-on-Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival. (18 citations)
  • Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report. (11 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His primary areas of study are Internal medicine, Gastroenterology, Liver disease, Cirrhosis and Coagulation. His research in Internal medicine is mostly focused on Thrombosis. His Gastroenterology study incorporates themes from Hemostasis, Fibrinolysis, Thrombin and MEDLINE.

His Liver disease study combines topics in areas such as Chronic liver disease, Fresh frozen plasma and Surgery, Sepsis. Ton Lisman interconnects Thrombelastography, Thrombomodulin, Thrombin generation and Hemostatics in the investigation of issues within Cirrhosis. Ton Lisman has included themes like Antithrombin, Prothrombin time and Von Willebrand factor in his Coagulation study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences

Ton Lisman;Robert J. Porte.
Blood (2010)

552 Citations

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Ton Lisman;Ton Lisman;Tamara N. Bongers;Jelle Adelmeijer;Harry L.A. Janssen.
Hepatology (2006)

516 Citations

Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management

Stephen H. Caldwell;Maureane Hoffman;Ton Lisman;B. Gail Macik.
Hepatology (2006)

465 Citations

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Mirjam E. Meltzer;Mirjam E. Meltzer;Ton Lisman;Ton Lisman;Philip G. de Groot;Joost C.M. Meijers.
Blood (2010)

372 Citations

Hemostasis and thrombosis in patients with liver disease: The ups and downs

Ton Lisman;Stephen H. Caldwell;Andrew K. Burroughs;Patrick G. Northup.
Journal of Hepatology (2010)

368 Citations

Thrombin-Activatable Fibrinolysis Inhibitor Deficiency in Cirrhosis Is Not Associated With Increased Plasma Fibrinolysis

Ton Lisman;Frank W.G. Leebeek;Laurent O. Mosnier;Bonno N. Bouma.
Gastroenterology (2001)

305 Citations

Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1

Robert Jan Lebbink;Talitha Eshuis-de Ruiter;Jelle Adelmeijer;Arjan B. Brenkman.
Journal of Experimental Medicine (2006)

282 Citations

Reduced Plasma Fibrinolytic Potential Is a Risk Factor for Venous Thrombosis.

Ton Lisman;Philip G. de Groot;Joost C.M. Meijers;Frits R. Rosendaal.
Blood (2004)

275 Citations

Haemostatic abnormalities in patients with liver disease

Ton Lisman;Frank W.G. Leebeek;Philip G. de Groot.
Journal of Hepatology (2002)

251 Citations

Lupus anticoagulants and the risk of a first episode of deep venous thrombosis

P. G De Groot;B. Lutters;R. H. W. M. Derksen;T. Lisman.
Journal of Thrombosis and Haemostasis (2005)

241 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ton Lisman

Robert J. Porte

Robert J. Porte

University Medical Center Groningen

Publications: 64

Richard W. Farndale

Richard W. Farndale

University of Cambridge

Publications: 47

Stephen H. Caldwell

Stephen H. Caldwell

University of Virginia

Publications: 46

Darius F. Mirza

Darius F. Mirza

Queen Elizabeth Hospital Birmingham

Publications: 35

Peter J. Lenting

Peter J. Lenting

University of Paris-Saclay

Publications: 27

Pierre-Alain Clavien

Pierre-Alain Clavien

University of Zurich

Publications: 26

James F. Markmann

James F. Markmann

Harvard University

Publications: 23

Pier Mannuccio Mannucci

Pier Mannuccio Mannucci

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Publications: 22

Francesco Violi

Francesco Violi

Sapienza University of Rome

Publications: 19

Martin L. Yarmush

Martin L. Yarmush

Rutgers, The State University of New Jersey

Publications: 18

Peter J. Friend

Peter J. Friend

University of Oxford

Publications: 18

Paul Declerck

Paul Declerck

KU Leuven

Publications: 18

Marcel Levi

Marcel Levi

University College London Hospitals NHS Foundation Trust

Publications: 18

Maureane Hoffman

Maureane Hoffman

Duke University

Publications: 17

Frits R. Rosendaal

Frits R. Rosendaal

Leiden University Medical Center

Publications: 17

William M. Lee

William M. Lee

The University of Texas Southwestern Medical Center

Publications: 17

Trending Scientists

Dimitris A Pados

Dimitris A Pados

Florida Atlantic University

Xiaoming Yuan

Xiaoming Yuan

University of Hong Kong

Koenraad M. R. Audenaert

Koenraad M. R. Audenaert

Royal Holloway University of London

Armen Sarvazyan

Armen Sarvazyan

Russian Academy of Sciences

Rui Xiao

Rui Xiao

Southeast University

Yves Gnanou

Yves Gnanou

King Abdullah University of Science and Technology

Chae-Ho Shin

Chae-Ho Shin

Chungbuk National University

Zushu Hu

Zushu Hu

Chinese Academy of Sciences

Mingwu Shen

Mingwu Shen

Donghua University

Lynda M. Rose

Lynda M. Rose

Brigham and Women's Hospital

Kurt D. Fausch

Kurt D. Fausch

Colorado State University

Adibe Luiz Abdalla

Adibe Luiz Abdalla

Universidade de São Paulo

Paul Brown

Paul Brown

National Institutes of Health

Hong Huo

Hong Huo

Tsinghua University

Audrey de Nazelle

Audrey de Nazelle

Imperial College London

Something went wrong. Please try again later.